Hu, Xiaosong
Liu, Ruochen
Hou, Jianbing
Peng, Wen
Wan, Sicheng
Xu, Minghao http://orcid.org/0000-0003-0535-8231
Li, Yongsen
Zhang, Guanghui
Zhai, Xuan
Liang, Ping http://orcid.org/0000-0002-8305-1326
Cui, Hongjuan http://orcid.org/0000-0002-9069-8670
Article History
Received: 17 October 2021
Revised: 21 July 2022
Accepted: 26 July 2022
First Online: 17 August 2022
Competing interests
: The authors declare no competing interests.
: All experiments involving cancer patients’ samples were obtained from Chaoying Biotechnology Co., Ltd. (Henan, China), and the studies were approved by the Medical Ethics Committee of Tongxu County People’s Hospital of Henan Province. All of the patients were informed consent.